\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ none\\ needed\\.\ \(2\)\
\-\ multiple\\ axial\\ ct\\ images\\ through\\ the\\ liver\\ demonstrate\\ multiple\\,\\ well\\-defined\\ hypodense\\ lesions\\.\\ \\ on\\ early\\ arterial\\ phase\\ images\\,\\ the\\ masses\\ demonstrate\\ peripheral\\ nodular\\ enhancement\\ with\\ progressive\\ filling\\-in\\ from\\ the\\ periphery\\ on\\ portal\\-venous\\ phase\\ images\\.\\ \\ delayed\\ images\\ show\\ prolonged\\ enhancement\\.\ \(0\)\
\-\ cavernous\\ hemangiomas\ \(3\)\
\-\ these\\ findings\\ are\\ classic\\ for\\ hemangioma\\.\\ \\ however\\,\\ the\\ differential\\ for\\ a\\ solid\\ liver\\ mass\\ includes\\:\ \(0\)\
\-\ metastases\ \(207\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ fibrolamellar\\ carcinoma\ \(1\)\
\-\ lymphoma\ \(373\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ 53\\ year\\ old\\ male\\ with\\ incidental\\ finding\\ of\\ a\\ liver\\ \\"mass\\"\\ on\\ ultrasound\\.\\ \\ patient\\ asymptomatic\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ liver\\:\\ 0\\.29977807538499157\ \(0\)\
\-\ images\\:\\ 0\\.26801590296053535\ \(0\)\
\-\ phase\\:\\ 0\\.24789916865651973\ \(0\)\
\-\ nodular\\:\\ 0\\.23070660467190546\ \(0\)\
\-\ carcinoma\\:\\ 0\\.17328856784853616\ \(0\)\
\-\ enhancement\\:\\ 0\\.16674928103126338\ \(0\)\
\-\ hemangiomas\\:\\ 0\\.15825478671369952\ \(0\)\
\-\ demonstrate\\:\\ 0\\.15060971369651602\ \(0\)\
\-\ periphery\\:\\ 0\\.14614411176150607\ \(0\)\
\-\ multiple\\:\\ 0\\.14170112787590944\ \(0\)\
\-\ hypodense\\:\\ 0\\.14065349399429727\ \(0\)\
\-\ prolonged\\:\\ 0\\.14030323605884967\ \(0\)\
\-\ 53\\:\\ 0\\.1355578032808444\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.13205902070584216\ \(0\)\
\-\ on\\:\\ 0\\.13124392337839055\ \(0\)\
\-\ cavernous\\:\\ 0\\.12564939854101936\ \(0\)\
\-\ hemangioma\\:\\ 0\\.12184686936307254\ \(0\)\
\-\ needed\\:\\ 0\\.11959535644306586\ \(0\)\
\-\ arterial\\:\\ 0\\.11928940939609911\ \(0\)\
\-\ the\\:\\ 0\\.11561337721975362\ \(0\)\
\-\ adenoma\\:\\ 0\\.11548385942416185\ \(0\)\
\-\ delayed\\:\\ 0\\.1133508230654674\ \(0\)\
\-\ includes\\:\\ 0\\.11263881480254923\ \(0\)\
\-\ solid\\:\\ 0\\.11105121676419175\ \(0\)\
\-\ progressive\\:\\ 0\\.11094152632270163\ \(0\)\
\-\ mass\\:\\ 0\\.11065966000042494\ \(0\)\
\-\ classic\\:\\ 0\\.10834280890944768\ \(0\)\
\-\ incidental\\:\\ 0\\.10737348138571433\ \(0\)\
\-\ early\\:\\ 0\\.10441430349513549\ \(0\)\
\-\ peripheral\\:\\ 0\\.10358166176202109\ \(0\)\
\-\ masses\\:\\ 0\\.09861288181140467\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.09861288181140467\ \(0\)\
\-\ finding\\:\\ 0\\.09521366127066885\ \(0\)\
\-\ differential\\:\\ 0\\.0941182072900689\ \(0\)\
\-\ show\\:\\ 0\\.09195576970974194\ \(0\)\
\-\ ultrasound\\:\\ 0\\.08934777826801643\ \(0\)\
\-\ for\\:\\ 0\\.0878074285548287\ \(0\)\
\-\ through\\:\\ 0\\.08622730743321459\ \(0\)\
\-\ however\\:\\ 0\\.08573580890781705\ \(0\)\
\-\ axial\\:\\ 0\\.08367207639317356\ \(0\)\
\-\ lesions\\:\\ 0\\.08319049686807259\ \(0\)\
\-\ these\\:\\ 0\\.08179824573242793\ \(0\)\
\-\ none\\:\\ 0\\.07916103509816175\ \(0\)\
\-\ findings\\:\\ 0\\.07149057291548108\ \(0\)\
\-\ male\\:\\ 0\\.06449395403287173\ \(0\)\
\-\ normal\\:\\ 0\\.059142349229982114\ \(0\)\
\-\ from\\:\\ 0\\.05752931542698843\ \(0\)\
\-\ with\\:\\ 0\\.056727903776532584\ \(0\)\
\-\ ct\\:\\ 0\\.05514674847376394\ \(0\)\
\-\ are\\:\\ 0\\.054964977492022726\ \(0\)\
\-\ patient\\:\\ 0\\.04711328214276219\ \(0\)\
\-\ year\\:\\ 0\\.044640722379668735\ \(0\)\
\-\ old\\:\\ 0\\.042870546254018524\ \(0\)\
\-\ of\\:\\ 0\\.0283470145538251\ \(0\)\
